Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology
Alan Rembach, Lisbeth A Evered, Qiao-Xin Lii, Tabitha Nash, Lesley Vidaurre, Christopher J Fowler, Kelly K Pertile, Rebecca L Rumble, Brett O Trounson, Sarah Maher, Francis Mooney, Maree Farrow, Kevin Taddei, Stephanie Rainey-Smith, Simon M Laws, S Lance Macaulay, William Wilson, David G Darby, Ralph N Martins, David Ames Show all
ALZHEIMERS RESEARCH & THERAPY | BIOMED CENTRAL LTD | Published : 2015
Awarded by NHMRC Practitioner Fellowship
This paper honors the contributions of Dr Alan Rembach as first author and his unexpected and untimely death during manuscript preparation. Core funding for the AIBL study was provided by CSIRO, which was supplemented by "in kind" contributions from the study partners (http://aibl.csiro.au). CSF collections were supported by Merck International. The research was also supported by the Science Industry and Endowment Fund (sief.org.au) and the National Health and Medical Research Council (NHMRC) via the Dementia Collaborative Research Centres program (DCRC). The Florey Institute of Neuroscience and Mental Health acknowledge funding support from the Victorian government's Operational Infrastructure Support program, Alzheimer's Australia (Victoria and Western Australia) assisted with promotion of the study. We would like to acknowledge Innogenetics (now Fujirebio) Europe N.V. Ghent, Belgium for supplying kits in the assay. We thank all those who took part as subjects in the study for their commitment and dedication to helping advance research into the early detection and causation of AD. S Collins is supported in part by an NHMRC Practitioner Fellowship (#APP1005816).